apollo
0

Welcome User

Login/Sign Up

Home
Buy Medicines
Lab Tests
Doctor Consult
Circle Membership
Insurance
Blogs
Contact Us
Privacy Policy
Return & Refunds
Need Help
Terms and Conditions
  1. Home
  2. Medicine

  3. Curosurf 120Mg/1.5Ml Inj

Curosurf 120Mg/1.5Ml Inj, Pack of 1
Written By Bayyarapu Mahesh Kumar , M Pharmacy
Reviewed By Dr Aneela Siddabathuni , MPharma., PhD
Non returnable*
Know More
COD available

Online payment accepted

rxMedicinePrescription drug

Whats That

tooltip

Composition :

PORACTANT ALFA-120MG

Manufacturer/Marketer :

Birla Healthcare Ltd

Consume Type :

PARENTERAL

Return Policy :

Not Returnable

Expires on or after :

About Curosurf 120Mg/1.5Ml Inj

Curosurf 120Mg/1.5Ml Inj belongs to a class of drugs called pulmonary surfactants. It is used to treat premature infants suffering from or at risk of a condition called respiratory distress syndrome (RDS). Respiratory distress syndrome, or RDS, is caused by insufficient surfactant in the lungs.

Curosurf 120Mg/1.5Ml Inj contains Poractant Alfa, a natural surfactant that works in the same way as human surfactant. It will help your baby breathe normally until it produces its own surfactant.

Curosurf 120Mg/1.5Ml Inj will be given to your baby in a hospital by a suitably trained doctor. In some cases, Curosurf 120Mg/1.5Ml Inj may cause a slow heart rate, low blood pressure, endotracheal tube blockage, and low blood oxygen levels.

The administration of Curosurf 120Mg/1.5Ml Inj to your newborn may impair your baby's lungs' ability to absorb oxygen. As a result, your baby will be closely monitored by a nurse or doctor so that oxygen and ventilatory support can be adjusted as needed. If your baby has any problems while being treated with Curosurf 120Mg/1.5Ml Inj, consult your doctor as soon as possible, even if you do not know the condition is related to the medicine.

Uses of Curosurf 120Mg/1.5Ml Inj

Respiratory distress syndrome (RDS)

Directions for Use

Curosurf 120Mg/1.5Ml Inj will be given to your baby in a hospital by a trained healthcare professional.

Medicinal Benefits

Curosurf 120Mg/1.5Ml Inj is a pulmonary surfactant. It is used to treat premature infants who have or are at risk of developing respiratory distress syndrome (RDS). Curosurf 120Mg/1.5Ml Inj contains Poractant Alfa, a natural surfactant that works similarly to human surfactant. As a result, it will assist your baby in breathing normally until they develop their own surfactant.

Storage

Store in a cool and dry place away from sunlight

Drug Warnings

Before using Curosurf 120Mg/1.5Ml Inj, let your doctor know about all your children's medical conditions, sensitivities, and all medications used. The administration of Curosurf 120Mg/1.5Ml Inj to your newborn may impair your baby's lungs' ability to absorb oxygen. As a result, your baby will be closely monitored by a nurse or doctor so that oxygen and ventilatory support can be adjusted as needed. If your baby experiences any issues while being treated with Curosurf 120Mg/1.5Ml Inj, contact your doctor as soon as possible, even if you do not feel the problem is due to the medication.

Diet & Lifestyle Advise

NA

Habit Forming

No

Therapeutic Class

LUNG SURFACTANTS

Author Details

Bayyarapu Mahesh KumarDoctor badge

Written By

Bayyarapu Mahesh Kumar

M Pharmacy

Dr Aneela SiddabathuniDoctor badge

Reviewed By

Dr Aneela Siddabathuni

MPharma., PhD

Last Updated

Jul 8, 2025 | 9:49 AM IST

Doctor imageWe provide you with authentic, trustworthy and relevant information

FAQs

Curosurf 120Mg/1.5Ml Inj contains Poractant Alfa, a natural surfactant that works in the same way as human surfactant. It will, therefore, help your baby to breathe normally until your baby produces their own surfactant.

No, it is not necessary to use in all premature babies. It can be used only in premature infants suffering from or at risk of a condition called respiratory distress syndrome (RDS).

Please inform your doctor if your child has a history of liver diseases/conditions. Your doctor will weigh the benefits and potential risks before prescribing Curosurf 120Mg/1.5Ml Inj.Poractant Alfa is used to treat or prevent lung distress in premature babies.

Disease/Condition Glossary

Respiratory distress syndrome (RDS):  RDS is mainly caused when the baby's lungs do not have enough surfactant. The earlier the infant is born, the more probable they may have RDS. Under such conditions, the baby requires extra oxygen, which is done through ventilatory support.

Have a query?

Buy best Endocrine Disorders products by

whatsapp Floating Button
Buy Now
Add to Cart